These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3680316)

  • 1. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.
    Seymour LW; Duncan R; Strohalm J; Kopecek J
    J Biomed Mater Res; 1987 Nov; 21(11):1341-58. PubMed ID: 3680316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.
    Kissel M; Peschke P; Subr V; Ulbrich K; Schuhmacher J; Debus J; Friedrich E
    PDA J Pharm Sci Technol; 2001; 55(3):191-201. PubMed ID: 11417110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
    Lu ZR
    Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
    Duncan R; Kopecková P; Strohalm J; Hume IC; Lloyd JB; Kopecek J
    Br J Cancer; 1988 Feb; 57(2):147-56. PubMed ID: 3358905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.
    Lammers T; Peschke P; Kühnlein R; Subr V; Ulbrich K; Huber P; Hennink W; Storm G
    Neoplasia; 2006 Oct; 8(10):788-95. PubMed ID: 17032495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.
    Noguchi Y; Wu J; Duncan R; Strohalm J; Ulbrich K; Akaike T; Maeda H
    Jpn J Cancer Res; 1998 Mar; 89(3):307-14. PubMed ID: 9600125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biodistribution of N-(2-hydroxypropyl) methacrylamide copolymer-bound mitoxantrone in mice bearing Ehrlich solid tumor].
    Huang Y; Zhang Z; Liu W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):930-4. PubMed ID: 15646335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.
    Seymour LW; Miyamoto Y; Maeda H; Brereton M; Strohalm J; Ulbrich K; Duncan R
    Eur J Cancer; 1995; 31A(5):766-70. PubMed ID: 7640051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.
    Duncan R; Seymour LC; Scarlett L; Lloyd JB; Rejmanová P; Kopecek J
    Biochim Biophys Acta; 1986 Jan; 880(1):62-71. PubMed ID: 3942780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
    Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
    Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes.
    Bertrand N; Fleischer JG; Wasan KM; Leroux JC
    Biomaterials; 2009 May; 30(13):2598-605. PubMed ID: 19176241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation.
    Allmeroth M; Moderegger D; Biesalski B; Koynov K; Rösch F; Thews O; Zentel R
    Biomacromolecules; 2011 Jul; 12(7):2841-9. PubMed ID: 21692523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers.
    Callahan J; Kopečkov P; Kopeček J
    Biomacromolecules; 2009 Jul; 10(7):1704-14. PubMed ID: 21197960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biodistribution, excretion and potential toxicity of different-sized Pd nanosheets in mice following oral and intraperitoneal administration.
    Chen X; Li J; Huang Y; Wei J; Sun D; Zheng N
    Biomater Sci; 2017 Nov; 5(12):2448-2455. PubMed ID: 29082412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling, stability, and body distribution in rats, of low molecular weight polylactide homopolymer and polylactide-polyethyleneglycol copolymer.
    Bridges JF; Critchlow M; Irving MP; Purkiss SC; Taylor DC; Lloyd JB
    Biomaterials; 2000 Jan; 21(2):199-209. PubMed ID: 10632402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration.
    Yamaoka T; Tabata Y; Ikada Y
    J Pharm Pharmacol; 1995 Jun; 47(6):479-86. PubMed ID: 7674130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
    Buckway B; Wang Y; Ray A; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.